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Abstract:  Introduction: The Spanish Ministry of Health commissioned the Galician Agency for Health Technology 
Assessment to monitor and follow-up Autologous Chondrocyte Implantation (ACI) used to treat chondral lesions of the 
knee in Spain. The objective of this monitoring was to assess efficacy and safety of the technique. 
Design: One-hundred and eleven consecutive patients with knee chondral lesions were included in a multi-center study 
between January 2001 and January 2005. ACI was used in these patients as a second-line treatment option (or a first-line 
treatment option if the cause was Osteocondritis dissecans). The Cincinnati score and the Short Form 36 (SF-36) 
questionnaire were used to assess the patients’ self-reported satisfaction with the outcomes of ACI. A descriptive analysis 
was performed and non-parametric tests were used to establish correlations and compare results among subgroups. A 
multivariate analysis was also performed to measure the effect of different variables on changes in the condition of the 
knee. 
Results: Eighty men (72%) and 31 women (21%) with an age range from 16 to 49 years, underwent ACI surgery. Among 
these subjects, the most common previous first-line treatment was debridement (64 individuals, 74.4%). The mean size of 
the lesion treated with ACI was 3.82 cm
2, and the most frequent location of the lesion was the inner femoral condyle 
(53.6%). The patient satisfaction was high or very high in 36 subjects (66.7%). Overall knee joint assessment improved 
from 4.32 points to 6.78. All SF-36 questionnaire categories improved, notably those related to physical condition. 
Conclusions: The results of this study indicate that ACI is safe; however, further studies are mandated to assess the 
efficacy of ACI compared to alternative treatment options. 
Keywords: Chondrocytes, cartilage, clinical trial, implantation, ACI, transplant. 
INTRODUCTION 
 The  actual  incidence of knee cartilage injuries is 
unknown, partly because of the gap between occurrence of 
the primary lesion and the onset of symptoms [1]. According 
to previous studies, the prevalence of knee chondral lesions 
is estimated to be 60-63%  of the population undergo 
arthroscopy. The medial femoral condyle and patella are the 
most commonly injured sites [2, 3]. 
  Several surgical procedures have been developed to treat 
chondral lesions [4, 5]. The primary aim of these techniques 
is to stop or delay the progression of cartilage degeneration 
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to osteoarthritis. Secondary objectives of these therapies are 
regeneration of the cartilage itself and decreasing the need 
for articular replacements. The procedures can be classified 
into four general categories: (a) symptomatic treatment, (b) 
stimulation of bone marrow, (c) chondrogenesis of tissue 
cells, and (d) transplantation of osteochondral plugs [6]. 
  One of the chondrogenesis techniques used is autologous 
chondrocyte implantation (ACI). This is a two-step 
procedure. First, normal cartilage tissue cells are extracted 
from a non-weight-bearing area of the knee. These isolated 
cartilage cells are cultured and then implanted onto the 
chondral defect. Classically, a periosteum cover is used to 
retain the implant in situ. Newer variations of ACI use 
collagenous membranes or a laboratory-formed matrix to 
keep the cell transplant in place [7-9]. Spanish Experience in Autologous Chondrocyte Implantation  The Open Orthopaedics Journal, 2010, Volume 4    15 
  In this paper, we present a Spanish multi-center case 
series with five years of follow-up. The objectives of this 
study are to assess the safety of ACI and its efficacy in terms 
of clinical outcomes, quality of life and patient satisfaction. 
SUBJECTS AND METHODS 
Setting 
  An agreement between the Spanish Ministry of Health 
and Regional Departments of Health commissioned the 
Galician Agency for Health Technology Assessment 
(AVALIA-t) to monitor and follow-up ACI procedures in 
Spain. The aim of this monitoring (known as tutelage) was 
to assess the efficacy and safety of the technique in order to 
consider it for inclusion in the services portfolio of the 
National Health System. Seven Spanish hospitals 
collaborated in this study: Santiago de Compostela 
University Hospital (Santiago de Compostela), Miguel 
Servet Hospital (Zaragoza), Dr. Peset Hospital (Valencia), 
Juan Canalejo University Hospital (A Coruña), Río Hortega 
University Hospital (Valladolid), La Paz Hospital (Madrid), 
and Santa Teresa Policlinic Institute (A Coruña). 
Study Design 
  A consensus protocol was developed to perform a 
prospective follow-up examination of ACI procedures. All 
consecutive ACI procedures done between April 1, 2001 and 
January 15, 2005 at a collaborating center were incorporated 
into the “tutelage”. Tutelage modality is an open 
observational and prospective study supported by de Sapnish 
Health Government. 
  Inclusion criteria for this study included: symptomatic 
lesions involving full knee cartilage thickness, diameter of 
the defect between 2 and 9 cm
2, age of the subject between 
18- and 55-years-old, presence of disabling symptoms and 
failure of other conventional treatments. ACI would 
therefore be a second-line treatment, except in those subjects 
diagnosed with Osteocondritis dissecans (OCD) because 
ACI is considered to be the first-line treatment for this 
condition. 
 Exclusion  criteria  included:  degenerative conditions of 
the knee associated with osteoarthritis and hypersensitivity 
to any component of the culture media, such as antibiotics. 
  After surgery (using periostium to cover the lesion) and 
chondrocyte implantation, subjects were not given a 
standardized protocol of physiotherapy. Each hospital used 
its own protocol for re-establishing knee movement post-
operatively. 
Data Capture 
  Data pertaining to sex, age, occupation, previous 
surgeries, cause of the lesion, and site of the lesion, 
concurrent pathologies, physical activity and allergies were 
collected preoperatively. Arthroscopy provided size 
measurements and macroscopic assessment of the lesion. 
Follow-up assessments collected data relative to subject 
overall satisfaction (graded very high, high, low, very low, 
and not satisfied at all). Validated questionnaires, such as the 
Cincinnati knee-evaluation score and Short Form 36 
questionnaire (SF-36), were used to retrieve clinical and 
quality of life assessments. 
  The Cincinnati questionnaire was collected preopera-
tively and at standard follow-up intervals of 15 days, 1.5, 
three and six months, and one, two, three, four and five 
years. The SF-36 form was filled out preoperatively and at 
six months and one, three and five years. All data were 
collected by hospital consultants and sent to avalia-t every 
six to nine months. 
Statistical Analysis 
  Data were managed with SPSS 12.0 software (Chicago, 
USA). The data were first screened to eliminate abnormal 
values and mistakes produced during the data collection 
process. A descriptive analysis was performed using SPSS 
12.0 and EXCEL software. Non-parametric tests were used 
to assess correlations (Spearman’s rho) and to compare 
results among subgroups (Mann-Whitney U-test). Subgroups 
were defined according to the following: fulfilling the 
inclusion criteria (e.g., some patients underwent ACI without 
meeting the inclusion criteria), existence of previous 
surgeries, diagnosis of OCD age (two subgroups were 
defined as 30-years-old or less and over 30-years-old), and 
location of the chondral lesion. A multivariate analysis was 
also performed to measure the impact of different variables 
on the condition of the knee after ACI. 
  After analyzing the subgroups, 14 subjects who did not 
meet the standard inclusion  criteria were included in the 
analysis: some failed to report a previous surgery and others 
suffered injuries affecting less than 50% of the cartilage 
thickness. The decision to retain the data from these subjects 
was made after demonstrating by subgroup analysis that their 
results did not differ from the rest. 
RESULTS 
Subject Characteristics 
  A total of 111 subjects were included from Santiago de 
Compostela University Hospital (55); Miguel Servet 
Hospital (22); Dr. Peset Hospital (10); Juan Canalejo 
University Hospital (9); Río Hortega University Hospital (7); 
La Paz Hospital (6) and Santa Teresa Policlinic Institute (2). 
Among the subjects were 80 males (72.1%) and 31 females 
(29.1%) (Table 1) with an overall mean age of 30.9 years 
(95% confidence interval: 29.1-32.7). The right knee was 
more frequently affected than the left knee (56% vs 44%). 
Interestingly, 76.5% of the subjects showed no concurrent 
pathology and trauma was the most frequent etiology 
(30.6%), (Table 1). OCD was diagnosed in 22.5% of the 
subjects (Table 1). Debridement constituted 74.4% of 
previous surgeries in those subjects receiving ACI as a 
second-line therapy. Chondral lesions were more frequent in 
the medial condyle (53.6%) (Table 1) and the mean size of 
the lesions was 3.8 cm
2. 
  The rate of participation by the subjects decreased over 
the follow-up period, being approximately 65% at two years, 
60% at three years and 25% at five years (Table 2). 
Clinical Efficacy 
  The daily activities portion of the Cincinnati 
questionnaire revealed the following assessment of the knee 
condition of the subjects (Table 3): 68.9% of the subjects 
had no walking limitations, 28% had mild limitations and  
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Table  1.  Baseline Characteristics of Subjects Receiving 
Autologous Chondrocyte Implantation (ACI) to 
Treat Chondral Lesions of the Knee 
 
Characteristics N  Percentages  
(%) 
Males 80  72.1 
Sex 
Females 31  27.9 
Unknown 25  22.5 
Student 16  14.4 
Worker/bricklayer 11  9.9 
Occupation 
Other 59  53.2 
Unknown 44  39.6 
Traumatic 34  30.6 
Osteocondritis dissecans (OCD)  25  22.5 
Cause of the Lesion 
Other 8  7.3 
Medial femoral condyle  59  53.6 
Lateral femoral condyle  8  7.2 
Trochlea 9  8.2 
Patella 18  16.4 
Site 
Other 17  14.6 
 
only 3.2% had moderate or severe limitations at three years 
of follow-up. The stair climbing and descending results 
showed that 89% and 100% of the subjects had no or mild 
limitations at three and five years, respectively. Severe 
limitations to kneeling down were also low at three (13%) 
and five years (0%) of follow-up. Interestingly, all subjects 
improved in all aspects of daily activities following ACI 
(Table 3). 
 Sporting  activity  ratings  at three years of follow-up 
showed that 43% of the subjects had severe or moderate 
running limitations and 46% had severe or moderate jumping 
limitations. However the percentage of subjects with severe 
limitations to running or jumping was considerably reduced 
compared with the pre-surgical assessment: running, 54% vs 
15%; and jumping: 71 vs 31% (Table 4). 
  Physical examinations revealed mild to moderate joint 
effusions in 13.6% of the subjects after three years, however 
none were severe and no moderate joint effusions were 
observed in follow-up years four and five (Table 5). 
Approximately 10% of the subjects showed mild to moderate 
knee flexion or extension reduction at three years follow-up 
(Table 5). 
  To perform the subgroup analysis we considered changes 
in the condition of the knee  as a  dependent variable. The 
condition of the knee was measured as the difference 
between the pre-operative and post-operative follow-up 
Table 2.  Participation of Subjects Receiving Autologous Chondrocyte Implantation (ACI) to Treat Chondral Lesions of the Knee 
During the Five-Year Follow-Up 
 
 Baseline  15 d  1.5 m  3 m  6 m  1 y  2 y  3 y  4 y  5 y 
Expected Cases  111  110 110 110 110 110 110  98  71  25 
Analysed Cases*  110 52 81 98 96 92 71 61 12  6 
Percentage of Analysed Cases (%)  99.1  47.3 73.6 89.1 87.3 83.6 64.5 62.2 16.9  24 
d = day; m = month; y = year. 
*We did not receive preoperative assessment in one case. 
 
Table 3.  Cincinnati Questionnaire: Daily Activities of Subjects Receiving Autologous Chondrocyte Implantation (ACI) to Treat 
Chondral Lesions of the Knee 
 
Item  Grade of Limitation  Pre-Surgery  1 Year  2 Years  3 Years  4 Years  5 Years 
No  Limitation  24.8%  48.9% 59.2% 68.9% 75.0% 66.7% 
Limitation  mild  41.6%  42.4% 35.2% 27.9% 25.0% 33.3% 
Limitation  moderate  23.9%  8.7% 4.2% 1.6% 0.0% 0.0% 
Walking 
Limitation  severe  9.7%  0.0% 1.4% 1.6% 0.0% 0.0% 
No  Limitation  16.8%  35.2% 40.3% 42.6% 66.7% 66.7% 
Limitation  mild  41.6%  49.5% 50.0% 45.9% 25.0% 33.3% 
Limitation  moderate  17.7%  8.8% 4.2% 6.6% 8.3% 0.0% 
Stair Climbing and Descending 
Limitation  severe  23.9%  6.6% 5.6% 4.9% 0.0% 0.0% 
No  Limitation  7.9%  19.6% 20.8% 33.3% 25.0% 66.7% 
Limitation  mild  31.9%  52.2% 48.6% 45.0% 50.0% 33.3% 
Limitation  moderate  17.7%  9.8% 15.3% 8.3%  0.0%  0.0% 
Kneeling 
Limitation  severe  42.5%  18.5% 15.3% 13.3% 25.0%  0.0% Spanish Experience in Autologous Chondrocyte Implantation  The Open Orthopaedics Journal, 2010, Volume 4    17 
assessments. At three years of follow-up, this subgroup 
analysis found no differences related to the fulfilment of the 
inclusion criteria, presence of associated pathologies, site of 
the lesion, or presence of OCD (Fig. 1). A significant 
association was found between age and the condition of the 
knee (p = 0.046) when we compared subjects less than or 
equal to 30-years-old with subjects greater than 30-years-old, 
which suggests poorer outcomes for older patients (Fig. 1). 
We also found a significant difference related to knee 
condition between subjects with previous surgeries and those 
with no earlier surgery; knees not undergoing previous 
surgery had better outcomes (p = 0.041) (Fig. 1). No 
significant differences were obtained at four and five years 
of follow-up because of the limited number of observations 
(Table  2). Fig. (1) shows some of the trends revealed by 
subgroup analysis. 
Patient Satisfaction and Quality of Life 
  The results of questions regarding pain, swelling, 
blockage of knee and general condition of the knee, 
according to the Cincinnati questionnaire, demonstrated that 
the outcomes were favourable. The poorest values (2-3 
points) were present at 15 days after surgery; however, after 
three and five years follow-up, the results (7-10 points) 
showed a nearly normal knee (Fig. 2). Self-assessed subject 
satisfaction was rated as high or very high by 67.4% of the 
subjects at the one year follow-up, 71.2%  at two years, 
66.6% at three years, 90.9% at four years and 50.0% at five 
years (Table 6). 
  In addition, the quality of life of the subjects, as reflected 
by the SF-36 questionnaires increased throughout the follow-
up period. The most improved paramenters were physical 
Table 4.  Cincinnati Questionnaire: Sport Activities in Subjects Receiving Autologous Chondrocyte Implantation (ACI) to Treat 
Chondral Lesions of the Knee 
 
Item  Grade of Limitation  Pre-Surgery  1 Year  2 Years  3 Years  4 Years  5 Years 
No  Limitation  3.5%  12.0% 15.7% 19.7% 16.7% 33.3% 
Limitation  mild  22.1% 31.5% 35.7% 37.7% 50.0% 33.3% 
Limitation  moderate  20.4% 23.9% 21.4% 27.9% 16.7% 33.3% 
Running 
Limitation  severe  54.0% 32.6% 27.1% 14.8% 16.7%  0.0% 
No  Limitation  3.6%  7.6%  9.9%  18.0% 16.7% 33.3% 
Limitation  mild  15.2% 31.5% 40.8% 36.1% 58.3% 66.7% 
Limitation  moderate  10.7% 18.5% 12.7% 14.8% 16.7%  0.0% 
Jumping 
Limitation  severe  70.5% 42.4% 36.6% 31.1%  8.3%  0.0% 
No  Limitation  4.4%  8.8%  8.5%  16.4% 16.7% 33.3% 
Limitation  mild  5.3%  25.3% 35.2% 36.1% 50.0% 66.7% 
Limitation  moderate  18.6% 23.1% 14.1% 19.7% 25.0%  0.0% 
Twisting 
Limitation  severe  71.7% 42.9% 42.3% 27.9%  8.3%  0.0% 
 
Table 5.  Cincinnati Questionnaire: Physical Examinations of Subjects Receiving Autologous Chondrocyte Implantation (ACI) to 
Treat Chondral Lesions of the Knee 
 
Item  Grade of Limitation  Pre-Surgery  1 Year  2 Years  3 Years  4 Years  5 Years 
No  Limitation  73.2%  93.3% 91.3% 86.4% 75.0% 50.0% 
Limitation  mild  22.6%  6.7%  7.2%  11.9% 25.0% 50.0% 
Limitation  moderate  2.1%  0.0% 1.4% 1.7% 0.0% 0.0% 
Joint Effusion 
Limitation  severe 2.1%  0.0% 0.0% 0.0% 0.0% 0.0% 
No  Limitation  82.0%  90.0% 92.8% 89.8% 91.7% 83.3% 
Limitation  mild  9.5%  5.6% 4.3% 6.8% 8.3%  16.7% 
Limitation  moderate  5.3%  3.3% 2.9% 3.4% 0.0% 0.0% 
Reduction of Flexion 
Limitation  severe 3.2%  1.1% 0.0% 0.0% 0.0% 0.0% 
No  Limitation  88.3%  92.1% 97.1% 89.8% 100%  100% 
Limitation  mild  7.4%  5.6% 2.9%  10.2%  0.0% 0.0% 
Limitation  moderate  3.2%  2.2% 0.0% 0.0% 0.0% 0.0% 
Reduction of Extension 
Limitation  severe 1.1%  0.0% 0.0% 0.0% 0.0% 0.0% 18    The Open Orthopaedics Journal, 2010, Volume 4  Pérez-Cachafeiro et al. 
role and physical function, while mental health showed the 
least improvement (Fig. 3). 
Adverse Events 
  The incidence of reported adverse events was low. 
During the first year, 19 adverse events were reported 
including joint effusions (9), infections (4), blockages (3), 
patellar misalignment (1), displaced grafts (1) and adhesions 
(1). Treatment was necessary for 18 of these subjects and 
additional surgery was needed in eight cases. During the 
second year, two adverse events occurred related to mild to 
moderate pain. Five further pain episodes were treated in the 
 
Fig. (1). Development of pain, swelling, and blockage according to Cincinnati questionnaires. 
 
Fig. (2). Subgroup analysis. 
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third year of follow-up; and no adverse events were reported 
at later follow-ups. No graft failures occurred in the subject 
group. 
DISCUSSION 
  This study represents not only the largest Spanish ACI 
case series, but one of the largest worldwide. The results 
were influenced by participation rates (Table 2), particularly 
the number of subjects completing the three, four and five 
year follow-ups. Overall, high or very high levels of 
satisfaction were self-reported by 69.6% of the subjects at 
their last  follow-up (median: 3 years; range: 2-5 years). 
During the first six months of the study, the activities of the 
subjects were limited because of rehabilitation protocols; 
therefore improvements were not considered satisfactory 
until the first year when Cincinnati scores exceeded 6. 
However, clinical improvements progressed throughout the 
whole follow-up period. Because the number of 
complications and adverse events reported was relatively 
low, safety issues were not a concern. 
  Overall satisfaction levels in our study are slightly lower 
than those published in previous studies [6]. Peterson et al. 
obtained high/very high satisfaction in up to 91% of patients 
after two years follow-up and in 76% when they considered 
a two to nine year interval [10-12]. In a 50 patient case-
series, Micheli et al. found high satisfaction in 83% of 
subjects [13]. Because the satisfaction percentages were 
consistent over time in our study, there may be a group (30% 
of our subjects) resistant to the treatment. However, it is 
difficult to compare the results of different studies to assess 
this because the follow-up periods are not uniform. Another 
possible explanation for our lower percentage of satisfaction 
may be that ACI was carried out as a second option, and the 
subjects could have higher expectations for this therapy. 
  Changes over time in pain, stiffness and blockage were 
positive. By the first year of follow-up, knee joint condition 
achieved a  value of  6 points (“able to do light work or 
sports”), representing a good result. After year three, a third 
of the subjects had moderate to severe limitation in daily 
activities,  such as walking or climbing stairs. This 
percentage decreased to zero by the fifth year, although 
about one-third still  suffered mild limitations. Fewer 
restrictions related to sports activities were reported as 
follow-up time increased. Occupational scores also reflected 
greater improvement with longer follow-ups. 
  Knee joint condition improved from 3.72 point 
preoperatively to 6.1 at one year, 6.4 at two years, 6.8 at 
three years, 7.4 at four years and 7.7 at five years. These 
Table 6.  Patient Self-Assessment of Grade of Satisfaction of Subjects Receiving Autologous Chondrocyte Implantation (ACI) to 
Treat Chondral Lesions of the Knee 
 
Grade of Satisfaction  1 Year  2 Years  3 Years  4 Years  5 Years 
Very High  19.1% 27.3% 33.3% 27.3% 25.0% 
High  48.3% 43.9% 33.3% 63.6% 25.0% 
Low  24.7% 22.7% 29.6%  9.1%  50.0% 
Very Low  3.4% 6.1% 3.7% 0.0% 0.0% 
None  4.5% 0.0% 0.0% 0.0% 0.0% 
 
 
Fig. (3). Changes in SF-36 items. 
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results are similar to those of other investigators [12-14]. 
However, in previously published studies, patients were 
reported to improve more quickly than in our case-series 
(joint condition values between 7 and 9 after one to two 
years of follow-up). This fact could be due to better 
preoperative conditions in our population and, consequently, 
to a regression to the mean effect [12]. 
  The subgroup analysis showed an association of better 
outcomes with younger ages and with no previous surgery. 
There is a trend (Fig. 2) indicating a possible link between 
OCD etiology and better outcomes, although this association 
could be due to the confounding effect of age because 
patients with OCD tend to be younger. These results are 
consistent with previous studies that have reported greater 
improvements in younger patients [15-18]. There are few 
studies examining the effect of age on results from ACI, in 
spite of the fact that it appears to be an important variable in 
determining results. 
  Even though we anticipated that concurrent pathologies 
would worsen clinical outcomes, we could not demonstrate 
this effect. We consider this finding to need further research, 
because other authors have found better outcomes with 
isolated lesions [18-20], and the number of subjects with 
associated pathologies in our series was relatively low. 
  Quality of life has been reported in only a few studies, in 
which pain and physical aspects improved the most [21, 22]. 
We found overall improvement in the whole set of aspects 
evaluated in this questionnaire. Physical role, physical 
function, body pain and social role showed greater 
improvements while mental health showed the least 
improvement. 
  Nineteen subjects (18%) were reported to suffer 
complications during the first year of follow-up. Two 
additional subjects had experienced adverse events during 
the second year, and five more by the third year. Leakage 
(8.1%) and infection (3.6%) were the commonest adverse 
events. Other studies have reported higher rates of adverse 
events, with failure rates between 0 and 7.7%, mainly due to 
periosteum hypertrophy [10-14, 16, 19-21, 23]. A second 
intervention is required after graft failure. In our series, no 
failures were reported, although a second intervention was 
done in a patient with blockage. 
  Multi-center studies are scarce for procedures like ACI. 
The multi-centricity with a greater number of patients 
included in our study provides for increased validity over 
case studies from a single center. Furthermore, we provide 
an independent study, whereas most of published studies 
have conflicts of interest [24]. Although strength of our 
study is the multi-centre data collection, which provides a 
relatively large number of subjects, a concern is the lack of 
standardization of surgical and post-operative rehabilitation 
protocols, as found with many multi-center studies. The 
subjects followed a rehabilitation program according to the 
knee surgery  rehabilitation protocol of each hospital. 
However, some procedures were followed in all the 
hospitals. Weight-bearing status after surgery was restricted 
for three to six months and continuous passive motion 
(CPM) was started 24 hours after surgery and continued 
throughout hospitalization. Interestingly, although 
rehabilitation was not standardized, we did not find any large 
differences in the results from different hospitals. However, 
inter-hospital differences could explain some of the 
relatively small differences in patient satisfaction between 
our study and other reported studies. 
 A  main limitation of our study was the use of a case-
series design. Because of the lack of a control group, it is 
difficult to obtain causality associations. We, therefore, 
cannot definitively conclude that ACI is superior to other 
techniques. We were unable to evaluate the effect of 
different rehabilitation protocols because of the lack of a 
standardized protocol. Nevertheless, because clinical 
outcomes were good, we could consider that adequate 
rehabilitation protocols were implemented at all participating 
hospitals. 
CONCLUSIONS 
  Patients treated by ACI are quite satisfied with their 
outcomes and report good quality of life after the procedure. 
Clinical results were good in about 70% of patients based on 
their responses to our questionnaires. 
  Medium-term results (three to five years) show that ACI 
appears to be safe. The regeneration of hyaline-like cartilage 
is unknown because we could not obtain biopsies from our 
patients. Any effect attributable to rehabilitation program 
differences associated with ACI has not been investigated. In 
addition, cost appears to be a serious limitation to 
implementation of this procedure [25, 26]. The future of ACI 
depends on further investigations through well-designed 
randomized trials with long term follow-up. These studies 
should include the demonstration of  cartilage regeneration 
and reduction of the number of knee replacements in patients 
undergoing ACI. 
ABBREVIATIONS 
ACI =  Autologous  Chondrocyte  Implantation 
AVALIA-t  =  Galician Agency for Health Technology  
     Assessment 
CPM  =  Continuous passive motion 
OCD =  Osteocondritis  dissecans 
SF-36  =  Short Form 36 questionnaire 
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